[1] |
Nash K, Hafeez A, Hou S.Hospital-acquired renal insufficiency[J].Am J Kidney Dis,2002,39(5):930-936.
|
[2] |
Parfrey P.The clinical epidemiology of contrast-induced nephropathy[J].Cardiovasc Intervent Radiol,2005,28(Suppl 2):S3-S11.
|
[3] |
Dangas G, Iakovou I, Nikolsky E,et al.Contras-induced nephropaty after percutanetous in relation to chronic kidney disease and hemodynamic variables[J].Am J Cardiol,2005,95(1):13-19.
|
[4] |
Manske CL, Sprafka JM, Strony JT,et al.Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography [J].Am J Med,1990,89(5):615-620.
|
[5] |
De Broe ME, Porter GA, Bennett WM,et al.Clinical nephrotoxins:renal injury from drugs and chemicals[M].Kluwer Academic Publishers,2003.
|
[6] |
Nozue T, Michishita I, Iwaki T,et al.Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention[J].J Cardiol,2009,54(2):214-220.
|
[7] |
Mehran R, Nikolsky E.Contrast-induced nephropathy:definition,epidemiology,and patients at risk[J].Kidney Int Suppl,2006,100:S11-S15.
|
[8] |
Chong E, Poh KK, Liang S,et al.Risk fractors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine[J].Ann Acad Med Singapore,2010,39(5):374-380.
|
[9] |
Wang XC, Fu XH, Wang YB,et al.Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention:role of the ratio of contrast medium volume to estimated glomerular filtration rate[J].Chin Med J (Engl),2011,124(6):892-896.
|
[10] |
Ma YC, Zuo L, Chen JH,et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J].J Am Soc Nephrol, 2006,17(10):2937-2944.
|
[11] |
Liistro F, Falsini G, Bolognese L.The clinical burden of contrast media-induced nephropathy [J].Ital Heart J,2003,4(10):668-676.
|
[12] |
张洁,赵建华,王志英,等.高龄人造影剂肾病临床相关因素及预防措施[J].中华保健医学杂志,2009,11(4):286-288.
|
[13] |
Mueller C, Buerkle G, Buet tner HJ,et al.Prevention of contrast media-associated nephropathy:randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty [J].Arch Intern Med,2002,162(3):329-336.
|
[14] |
Esplugas E, Cequier A, Gomes-Hospital JA,et al.Comparative tolerability of contrast media used for coronary interventions[J].Drug Saf,2002,25(15):1079-1098.
|
[15] |
Nguyen SA, Suranyi P, Ravenel JG,et al.Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous cont rast-enhanced CT:effect on kidney function[J].Radiology,2008,248(1):97-105.
|
[16] |
Toprak O, Cirit M, Yesil M,et al.Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment[J].Kidney Blood Press Res,2006,29(1):2-9.
|
[17] |
Zhang Pian, Ni Zhaohui, Wang Ling,et al.A Multi-center clinical study of contrast-induced nephropathy in inpatients in cardiology department after coronary artery intervention[J].Chinese Journal of Blood Purification,2010,9(7):375-370.
|
[18] |
Bartholomew BA, Harjai KJ, Dukkipati S,et al.Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification[J].Am J Cardiol,2004,93(12):1515-1519.
|
[19] |
Nikolsky E, Mehran R, Turcot D,et al.Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneouscoronary intervention[J].Am J Cardiol, 2004,94(3):300-305.
|
[20] |
Asif A, Preston RA, Roth D.Radiocontrast-induced nephropathy[J].Am J Ther,2003,10(2):137-147.
|
[21] |
Rubenstein MH, Sheynberg BV, Harrell LC,et al.Effectiveness and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure[J].Am J Cardiol,2001,87(7):856-860.
|
[22] |
郭敏,邹阳春.造影剂肾病研究进展[J].中华高龄多器官疾病杂志,2010,9(3):286-288.
|
[23] |
Abe M, Kimura T, Morimoto T,et al.Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients[J].Circ J,2009,73(8):15l8-1522.
|
[24] |
Freeman RV, O’Donnell M, Share D,et al.Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose[J].Am J Cardiol,2002,90(10):1068-1073.
|
[25] |
Sherwin PF, Cambron R, Johnson JA,et al.Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy:correlation of D/CrCL with area under the contrast concentrationtime curve using iodixanol[J].Invest Radiol,2005,40(9):598-603.
|
[26] |
Worasuwannarak S, Pornratanarangsi S.Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI:role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio[J].J Med Assoc Thai,2010,93 (Suppl 1):S29-S34.
|
[27] |
National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39 (2 Suppl 1):S1-S266.
|
[28] |
杨志寅.现代医学科学发展中的缺憾与思考[J/CD].中华诊断学电子杂志,2013,1(1):1-7.
|